MIRA INFORM REPORT

 

 

Report Date :

20.09.2014

 

IDENTIFICATION DETAILS

 

Name :

COREY ORGANICS PRIVATE LIMITED (w.e.f. 06.07.2009)

 

 

Formerly Known As :

COREY ORGANICS LIMITED

 

 

Registered Office :

100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500038, Telangana

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

01.03.1996

 

 

Com. Reg. No.:

01-023399

 

 

Capital Investment / Paid-up Capital :

Rs.30.429 Millions

 

 

CIN No.:

[Company Identification No.]

U23231TG1996PTC023399

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDC00743B

 

 

PAN No.:

[Permanent Account No.]

AABCC3624L

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

The company is engaged in the business of Manufacturing of Bulk Drugs and Intermediates.

 

 

No. of Employees :

300 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (15)

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

The company reflects weak financial risk profile as the rating takes into consideration the delays by the company in servicing its debt obligations, the delays are because of the company’s weak liquidity on account of its working capital intensive operations.

 

However, business is active. Payment terms are reported to be slow.

 

The company can be considered for business dealings on a secured trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications: Apex court order may alter coal import dynamics. Traders go slowly on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

 

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn Business Empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M a M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that it had wilfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Rating = D

Rating Explanation

The company is in default or expected to be in default soon.

Date

23.04.2014

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Ms. Lavanya

Designation :

Accounts Executive

Contact No.:

91-40-23715528

 

 

LOCATIONS

 

Registered Office :

100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500038, Telangana, India

Tel. No. :

91-40-23715528

Fax No. :

91-40-23701738 

E-Mail :

coreyorganics@gmail.com

finance@coreyorganics.com

info@chavadipharma.com

info@coreyorganics.com

coreyfinance@gmail.com

Website :

www.chavadipharma.com

Location :

Owned

Locality :

Commercial

 

 

Factory 1 :

Shed No.1 and Plot No. 23,  IDA Kothur, Kothur (V and M),  Mahaboobnagar (District)  Anhdra Pradesh, India

Tel. No. :

91-8548-256246

Fax No. :

91-8548-256246

 

 

Factory 2 :

Plot No. 35, Road No : 01, Jawahar Lal Nehru Pharma City, Parawada, Vishakapatnam, Anhdra Pradesh, India

 

 

DIRECTORS

 

As on 30.09.2013

 

Name :

Devi Reddy Raja Kumar Reddy

Designation :

Managing Director

Address :

H. No. 100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500038, Andhra Pradesh, India

Date of Birth/Age :

20.08.1956

Date of Appointment :

01.03.1996

DIN No.:

00059112

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U23231TG1996PTC023399

COREY ORGANICS Private LIMITED

Managing director

01/04/2006

01/03/1996

--

Active

NO

2

U24110TG1996PTC023074

SRI CHAVADI PHARMA PRIVATE LIMITED

Managing director

06/09/2013

30/09/2005

--

Active

NO

 

 

Name :

Mr. Devereddy Vidna Reddy

Designation :

Director

Address :

100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500038, Andhra Pradesh, India

Date of Birth/Age :

27.04.1986

Date of Appointment :

30.09.2005

DIN No.:

00065644

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U23231TG1996PTC023399

COREY ORGANICS PRIVATE LIMITED

Director

30/09/2005

30/09/2005

--

Active

NO

2

U24232TG2010PTC068382

SAI SREYAS PHARMACEUTICAL PRIVATE LIMITED

Additional director

15/12/2011

15/12/2011

--

Active

NO

 

 

Name :

Mr. Vijayakumar Reddy Devireddi

Designation :

Director

Address :

4/468-2 Up Star, Vivekananda Nagar, Kadapa – 516001, Andhra Pradesh, India

Date of Birth/Age :

01.06.1950

Date of Appointment :

30.09.1999

DIN No.:

02653753

 

 

Name :

Deepna Devireddy

Designation :

Director

Address :

100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500038, Andhra Pradesh, India 

Date of Birth/Age :

19.02.1989

Date of Appointment :

10.02.2011

DIN No.:

03245840

 

 

KEY EXECUTIVES

 

Name :

Ms. Lavanya

Designation :

Accounts Executive

 

 

MAJOR SHAREHOLDERS

 

As on 30.09.2013

 

Names of Shareholders

No. of Shares

% of Holding

D. Rajakumar Reddy 

304285

10.00

D. Sailaja

304066

9.99

C. Giridhar Reddy

219

0.01

R.Sai Pradeep Reddy

398553

13.10

D. Deepna

818587

26.90

D. Vidna

597440

19.63

B. Dileep Kumar Reddy

592500

19.47

B. Saraswathi

27200

0.89

Total

3042850

100.00

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2013

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

The company is engaged in the business of Manufacturing of Bulk Drugs and Intermediates.

 

 

Exports :

 

Products :

Finished goods

Countries :

·         Pakistan

Germany

USA

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Suppliers :

Zhejiang Medicines and Health Products, China

 

 

Customers :

Euticals, USA

 

 

No. of Employees :

300 (Approximately)

 

 

Bankers :

·         State Bank of Hyderabad, 11602, 1st Floor, MJR Complex, NH-7, Shamshabad, SSI Branch, Ranga Reddy District, Hyderabad - 501218, Andhra Pradesh, India

 

 

Facilities :

SECURED LOANS

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Long Term Borrowings

 

 

Term Loans from SBH

16.634

23.464

Loan from APSFC

5.496

7.619

Loan from LIC of India

2.250

2.250

Vehicle Loan from Sundram Finane

0.153

0.398

Short Term Borrowings

 

 

Working capital loan from SBH

92.148

77.012

Total

116.681

110.743

 

Notes:

 

Long Term Borrowings

 

Loan from LIC of India is sactioned against Keymen Insurance Policy and secured by the said policy.

 

Term loans from APSFC and SBH is secured by Hypothecation of Stocks, Receivables and collateral security of Factory Land and Buildings, Plant and Machinery and further secured by personal guarantees of Directors of the company.

 

Short Term Borrowings


Working capital loan from State Bank of Hyderabad is secured by Hypothecation of Stocks, Book Debtors and Receivables and collateral security of Factory Land, Shed, Plant and Machinery and further secured by personal guarantee of Directors of the company.

 

 

 

Banking Relations :

--

 

 

Financial Institution:

Andhra Pradesh State Financial Corporation, 5-9-194, Chirag Ali Lane, P.B. No. 165, Hyderabad - 500001, Andhra Pradesh, India

 

 

Auditors :

 

Name :

Suryachandra and Associates

Chartered Accountants

Address :

H.No: 8-3-315/8,Plot No:10,Maruthi Nagar, Hyderabad – 500045, Andhra Pradesh, India

Tel. No.:

91-40-23752728

Mobile No.:

91-40-23752829

PAN No.:

ACFFS1012D

 

 

Associates :

·         Sri Chavadi Pharma Private Limited

·         Sri Gandi Anjaneya Ice Plant

 

 

CAPITAL STRUCTURE

 

As on 30.09.2013

 

Authorised Capital : Rs.50.000 Millions

 

Issued, Subscribed & Paid-up Capital : Rs.45.000 Millions

 

As on 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3500000

Equity Shares

Rs.10/- each

Rs.35.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3042850

Equity Shares

Rs.10/- each

Rs.30.429 Millions

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

30.429

24.840

21.739

(b) Reserves & Surplus

21.228

17.224

15.320

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

51.657

42.064

37.059

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

43.649

53.245

40.530

(b) Deferred tax liabilities (Net)

0.043

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

43.692

53.245

40.530

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

92.148

77.012

37.356

(b) Trade payables

67.350

57.614

60.805

(c) Other current liabilities

6.722

6.410

3.166

(d) Short-term provisions

1.210

1.560

4.332

Total Current Liabilities (4)

167.430

142.596

105.659

 

 

 

 

TOTAL

262.779

237.905

183.248

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

86.409

97.108

50.967

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

19.849

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.304

0.979

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

86.409

97.412

71.795

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

104.485

76.139

42.495

(c) Trade receivables

48.098

37.156

44.284

(d) Cash and cash equivalents

7.283

4.090

4.398

(e) Short-term loans and advances

16.504

23.108

20.276

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

176.370

140.493

111.453

 

 

 

 

TOTAL

262.779

237.905

183.248

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

 

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Revenue from Operations

264.774

244.606

211.359

 

 

Other Income

0.570

1.719

0.790

 

 

TOTAL                                     (A)

265.344

246.325

212.149

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

159.184

144.492

128.783

 

 

Changes in inventories and Work-in-progress

(34.753)

(14.508)

(7.832)

 

 

Employee benefits

21.676

16.925

10.810

 

 

Other expenses

79.365

70.707

54.863

 

 

Preoperative expenses written off

0.000

0.000

0.103

 

 

TOTAL                                     (B)

225.472

217.616

186.727

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

39.872

28.709

25.422

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

21.236

17.237

9.137

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

18.636

11.472

16.285

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

13.065

7.332

7.116

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)                 (G)           

5.571

4.140

9.169

 

 

 

 

 

Less

TAX                                                                  (H)

1.567

2.236

3.070

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX (G-H)                  (I)

4.004

1.904

6.099

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

28.899

35.477

9.767

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

1.32

0.77

2.81

Particulars

 

 

 

31.03.2014

 

Sales Turnover (Approximately)

 

 

360.000

 

 

The above information has been parted by Mr. Lavanya (Accounts Executive).

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

1.51

0.77

2.87

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

2.10

1.69

4.34

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

2.12

1.74

5.65

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.11

0.10

0.25

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

2.63

3.10

2.10

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.05

0.99

1.05

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Share Capital

21.739

24.840

30.429

Reserves & Surplus

15.320

17.224

21.228

Net worth

37.059

42.064

51.657

 

 

 

 

long-term borrowings

40.530

53.245

43.649

Short term borrowings

37.356

77.012

92.148

Total borrowings

77.886

130.257

135.797

Debt/Equity ratio

2.102

3.097

2.629

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

211.359

244.606

264.774

 

 

15.730

8.245

 

 

 


NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

211.359

244.606

264.774

Profit

6.099

1.904

4.004

 

2.89%

0.78%

1.51%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last four years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

Notes: The registered office of the company has been shifted from Shed No.1, IDA Kottur, Andhra Pradesh, India to the present address w.e.f. 29.07.2010.

 

 

UNSECURED LOANS:

 

Particulars

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

LONG TERM BORROWINGS

 

 

From Banks and Financial Institutions

7.202

15.343

From Directors and Share Holders

11.914

4.171

Total

19.116

19.514

 

 

GENERAL INFORMATION

 

The company is engaged in the business of Manufacturing of Bulk Drugs and Intermediates.

 

 

FINANCIAL PERFORMANCE

 

During the year 2012-13, the company has achieved a turnover of Rs.265.344 Millions and earned a net profit of Rs.5.571 Millions.

 

During the current financial year 2013-14 the results will be good and more encouraging than the previous year.

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10244607

07/09/2010

10,000,000.00

Andhra Pradesh State Financial Corporation

5-9-194, Chirag Ali Lane, P.B. No : 165, Hyderabad - 500001, Andhra Pradesh, India

A95442778

2

90134483

06/08/2004 *

1,350,000.00

State Bank Of Hyderabad

Ssi Branch, Shamshmard, Hyderabad, Andhra Pradesh, India

-

3

90133934

20/04/2013 *

143,500,000.00

State Bank Of Hyderabad

11 60 2, 1st Floor, Mjr Complex, Nh-7, Shamshabad,
Ssi Branch, Ranga Reddy District, Hyderabad - 501218, Andhra Pradesh, India

B73389652

*Date of modification Charges

 

 

FIXED ASSETS:

 

·         Land

Building

Plant and Machinery

Furniture and Fixtures

Lab Equipments

Electrical Equipments

Office Equipment/ Computers

Pollution Maintenance Equipment

Vehicles

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.81

UK Pound

1

Rs.100.06

Euro

1

Rs.78.47

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

VNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

2

OPERATING SCALE

1~10

2

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

2

--LEVERAGE

1~10

2

--RESERVES

1~10

--

--CREDIT LINES

1~10

--

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

15

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.